| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 39,950 | 70,066 | 50,864 | 53,499 | | Cost of Revenue | 8,552 | 11,494 | 11,944 | 12,545 | | | Gross Profit |
-
| 58,572 | 38,920 | 40,954 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,836 | 29,511 | 26,457 | 28,002 | | Non Recurring | 5,432 |
-
|
-
|
-
| | Others | 52,772 | 31,701 | 33,902 | 24,073 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (2,640) | (21,439) | (11,121) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (47,642) | (2,640) | (21,439) | (11,121) | | Interest Expense | 3,352 | 3,586 | 2,934 | 3,625 | | Income Before Tax | (50,994) | (6,226) | (24,373) | (14,746) | | Income Tax Expense | 546 |
-
|
-
| 22,725 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (51,540) | (6,226) | (24,373) | (37,471) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (51,540) | (6,226) | (24,373) | (37,471) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($51,540) | ($6,226) | ($24,373) | ($37,471) |
|
0.03% Nasdaq 
0.03 (5.75%) 
Income Statement
